文献速递腹部CT

一种用于胃癌HER2状态预测的新型CT栖息地放射组学方法

A Novel CT Habitat Radiomics Approach for HER2 Status Prediction in Gastric Cancer.
PubMed 文献 · Acad Radiol · 2026-03-18

本研究回顾性纳入两中心857例经病理证实的胃癌患者,基于增强静脉期CT提取放射组学特征并构建临床、Radscore、Habitat2、Habitat3、Habitat4及联合模型。训练队列中各模型AUC分别为0.68、0.78、0.75、0.90、0.78、0.94,联合模型在训练、测试及外部验证队列中预测性能均最优,其次为Habitat3。

要点

  • 基于增强静脉期CT的Habitat3模型在训练队列预测HER2状态AUC为0.90(95%CI 0.87-0.94)。
  • 联合模型(Habitat3加临床变量)训练队列AUC为0.94(95%CI 0.91-0.97),在训练、测试及外部验证队列中性能均最优。
  • Habitat3模型表现优于临床模型、Radscore、Habitat2及Habitat4模型。

核心结论

  • Habitat3模型可稳健预测胃癌HER2表达,联合模型进一步提高预测准确性,为术前无创HER2评估提供工具。

研究设计与样本

  • 回顾性研究,纳入两医疗中心857例经病理证实的胃癌患者;中心1的657例按7:3随机分为训练队列460例和测试队列197例,中心2的200例作为外部验证队列;基于增强静脉期CT图像提取放射组学特征生成Radscore。

关键影像表现/征象

  • 肿瘤感兴趣区经无监督聚类定义栖息地亚区,分别构建基于两个、三个和四个亚区的模型,依据预测准确性选择最优栖息地模型。
  • 训练队列中Habitat2、Habitat3、Habitat4模型AUC分别为0.75(95%CI 0.69-0.81)、0.90(95%CI 0.87-0.94)、0.78(95%CI 0.73-0.84)。

诊断标准与关键数值

  • 临床模型训练队列AUC为0.68(95%CI 0.62-0.75)。
  • Radscore模型训练队列AUC为0.78(95%CI 0.73-0.83)。
  • Habitat2模型训练队列AUC为0.75(95%CI 0.69-0.81)。
  • Habitat3模型训练队列AUC为0.90(95%CI 0.87-0.94)。
  • Habitat4模型训练队列AUC为0.78(95%CI 0.73-0.84),联合模型训练队列AUC为0.94(95%CI 0.91-0.97)。

临床应用与阅片要点

  • 基于增强静脉期CT的栖息地放射组学模型可用于术前无创预测胃癌HER2表达状态。
  • Habitat3模型预测性能优于临床模型、Radscore、Habitat2及Habitat4模型,联合模型性能最优。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Accurate preoperative evaluation of human epidermal growth factor receptor 2 (HER2) status is crucial for guiding personalized treatment in gastric cancer (GC). This study aimed to evaluate the clinical value of CT-based multi-subregion habitat radiomics for noninvasive preoperative prediction of HER2 expression.

MATERIALS AND METHODS: This retrospective study enrolled 857 pathologically confirmed GC patients from two medical centers. Patients were stratified into HER2-positive and HER2-negative groups according to postoperative pathology. At Center 1, 657 patients were randomly divided into training (n = 460) and testing (n = 197) cohorts (7:3 ratio), while 200 patients from Center 2 served as an external validation (ex-vad) cohort. Radiomics features were extracted from contrast-enhanced venous-phase CT images, and a radiomics score (Radscore) was subsequently generated. Tumor regions of interest underwent unsupervised clustering to define habitat subregions, forming models based on two, three, and four subregions. The optimal habitat model was selected based on predictive accuracy. A combined model integrating the optimal habitat model and key clinical features was subsequently constructed.

RESULTS: Six models were developed: clinical, Radscore, Habitat2, Habitat3, Habitat4, and combined (Habitat3 plus clinical variables). In the training cohort, area under the receiver operating characteristic (ROC) curve values were 0.68 (95% confidence intervals (CI), 0.62-0.75), 0.78 (0.73-0.83), 0.75 (0.69-0.81), 0.90 (0.87-0.94), 0.78 (0.73-0.84), and 0.94 (0.91-0.97), respectively. The combined model achieved superior predictive performance in both training, test and ex-vad cohorts, followed by Habitat3.

CONCLUSION: The Habitat3 model robustly predicts HER2 expression in GC. The combined model further improves predictive accuracy.

SUMMARY STATEMENT: This study developed CT-based radiomics habitat models for predicting HER2 expression in gastric cancer. Habitat3 achieved optimal performance, and its combination with clinical variables yielded superior efficacy and clinical applicability, providing a robust non-invasive tool for preoperative HER2 assessment in gastric cancer.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Yao X, Lin J, Hu C, et al. A Novel CT Habitat Radiomics Approach for HER2 Status Prediction in Gastric Cancer. Acad Radiol. 2026. PMID: 41851003. doi:10.1016/j.acra.2026.02.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。